Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Bacteriophages : Alternatives to Antibiotics and Beyond
| Bacteriophages : Alternatives to Antibiotics and Beyond |
| Autore | Suárez Pilar García |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (390 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
bacteriophages
dairy industry pathogens lactic acid bacteria fermentation failure biofilms antimicrobial resistance antimicrobials lysins horizontal gene transfer, transduction biofilm phage therapy resistance bacteriophage models agent based mass action bacterial phage resistance regression modeling MRSA Clostridium difficile Clostridium difficile infection microbiome in vitro fermentation model marine vibrios biological control aquaculture interactions vibriosis Aeromonas hydrophila Motile Aeromonas Septicemia MAS multiple-antibiotic-resistance striped catfish (Pangasianodon hypophthalmus) endolysin antibiotics one health protein engineering Aeromonas salmonicida furunculosis phage-resistant mutants proteins infrared spectroscopy lysin lytic enzyme peptidoglycan hydrolase antimicrobial antibacterial antibiotic resistance bacteriophage therapy Nagoya Protocol CRISPR CAS phage isolation phage resistance Staphylococcus Kayvirus Vibrio anguillarum fish larvae challenge trials phage display enzybiotics Bacteriophages diabetic foot ulcer osteomyelitis Staphylococcus aureus Antibiotic-resistant bacteria lysogenic conversion prophage induction read recruitment shiga toxin American Foulbrood phage Paenibacillus larvae Brevibacillus laterosporus treatment safety bystander phage therapy Mycobacterium smegmatis mycobacteriophages directed evolution PlyC CHAP protein net charge CBD-independent FoldX STEC-specific bacteriophage whole genome sequencing STEC O145 strains antimicrobial agent Pseudomonas aeruginosa dual-species antibiotic synergy simultaneous sequential microbiome therapy evolution |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Bacteriophages |
| Record Nr. | UNINA-9910557641503321 |
Suárez Pilar García
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
| Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment |
| Autore | Ferraris Davide Maria |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (128 p.) |
| Soggetto topico |
Research & information: general
Biology, life sciences |
| Soggetto non controllato |
Mycobacterium tuberculosis
line probe assay second-line drugs drug resistance XDR-TB MDR-TB omics analysis TB treatment system analysis Beijing B0/W148 Mycobacterium smegmatis imidazo[1,2-b][1,2,4,5]tetrazine MmpS5-MmpL5 efflux drug discovery tuberculosis immune activation HLA-DR CD38 treatment response Mycobacterium macrophage apoptosis effector cytokine microRNA Beijing genotype Central Asia Outbreak murine infection model Virulence pre-XDR-TB Mycobacterium avium unique metabolic pathways subtractive genomics drug target uncharacterized proteins BM-MSCs Mtb bone-homing stem cell niche latent tuberculosis relapse liposomes M. tuberculosis host-pathogen interactions immune response antitubercular drug discovery antitubercular treatments IL-18 IL-18BP IL-18R gene expression |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557291103321 |
|
Ferraris Davide Maria
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||